Conversely, several studies reported the overexpression of an Hh ligand, often Shh, and the Hh transcriptional targets GLI1 and Ptch1, thus activating the Hh pathway, in breast cancer [11, 16-19]. This evidence concerns the gene PTCH1 and breast carcinoma.